Akèy › Sarkom tisi mou
Etid klinik pou Sarkom tisi mou ap rekrite nan Etazini
136 etid pou Sarkom tisi mou ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX33 etid
- New York City, NY20 etid
- Boston, MA18 etid
- St. Louis, MO14 etid
- Los Angeles, CA13 etid
- Columbus, OH13 etid
- Washington, DC12 etid
- Memphis, TN11 etid
- Philadelphia, PA10 etid
- Nashville, TN9 etid
- Rochester, MN9 etid
- Queens, NY9 etid
- Aurora, CO9 etid
- Atlanta, GA8 etid
- Durham, NC8 etid
- Grand Rapids, MI8 etid
- Santa Monica, CA7 etid
- Greenburgh, NY7 etid
- Edison, NJ7 etid
- Baldwin Park, CA7 etid
- Chicago, IL7 etid
- Dallas, TX6 etid
- Miami, FL6 etid
- Orange, CA6 etid
- Staten Island, NY6 etid
- East Norwalk, CT6 etid
- New Rochelle, NY6 etid
- Mountain View, CA6 etid
- Baltimore, MD6 etid
- Birmingham, AL5 etid
- Omaha, NE5 etid
- Pittsburgh, PA5 etid
- Cleveland, OH5 etid
- Arlington, VA5 etid
- San Francisco, CA5 etid
- Cincinnati, OH5 etid
- San Antonio, TX4 etid
- Jacksonville, FL4 etid
- Minneapolis, MN4 etid
- Portland, OR4 etid
Pa eta
- Alabama6 etid
- Arizona6 etid
- Colorado13 etid
- Connecticut5 etid
- Distrik Columbia7 etid
- Florid20 etid
- Georgia10 etid
- Illinois9 etid
- Indiana4 etid
- Iowa4 etid
- Kalifòni41 etid
- Kansas4 etid
- Kentucky3 etid
- Lwizyàn3 etid
- Maryland11 etid
- Massachusetts19 etid
- Michigan11 etid
- Minnesota13 etid
- Missouri15 etid
- Nebraska5 etid
- New Jersey8 etid
- New Mexico3 etid
- New York28 etid
- North Carolina13 etid
- Ohio23 etid
- Oregon4 etid
- Pennsylvania15 etid
- South Carolina3 etid
- Tennessee19 etid
- Texas38 etid
- Utah5 etid
- Virginia7 etid
- Washington3 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07189871Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06498648FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Ap rekriteFaz 1
Laj 3 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT06865664Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks · Tout sèks · Mizajou Sep 28, 2026 · NCT01109394DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07229313Anti-GD2 ADC M3554 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06641908A Study of CRD3874-SI in People With Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06021626A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334Biomarkers of Resiliency In Childhood Cancer Surgery
Ap rekriteEtid obsèvasyon
Laj 3 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT06674811Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07062003First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06797999Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04577014Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Ap rekriteFaz 1
Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06644755Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05711615Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Ap rekriteFaz 1/2
Laj 12 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT07725380GRID Therapy for Extremity Soft Tissue Sarcoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06073067A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06760819Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Ap rekriteFaz 1
Laj 5 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT06156410Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05837767Serial MRI Scans During Radiation Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04188535Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.